{"altmetric_id":420156,"counts":{"readers":{"mendeley":6,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[1610],"posts_count":1},"total":{"posts_count":1}},"citation":{"altmetric_jid":"4f6fa50b3cf058f610003169","authors":["Melanie Brazil"],"doi":"10.1038\/nrd1093","endpage":"340","first_seen_on":"2011-10-19T17:44:06+00:00","issns":["1474-1776","1474-1784"],"journal":"Nature Reviews Drug Discovery","last_mentioned_on":1319040780,"links":["http:\/\/www.nature.com\/nrd\/journal\/v2\/n5\/full\/nrd1093.html"],"pubdate":"2003-05-01T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"},{"name":"Biological Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"340","subjects":["pharmacology","drugtherapy"],"title":"GPR40 no longer an orphan","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/diabetes-gpr40-longer-orphan"},"altmetric_score":{"score":5.824,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.824},"context_for_score":{"all":{"total_number_of_other_articles":3685110,"mean":4.9302723403875,"rank":520441,"this_scored_higher_than_pct":85,"this_scored_higher_than":3164513,"rank_type":"exact","sample_size":3685110,"percentile":85},"similar_age_3m":{"total_number_of_other_articles":66559,"mean":3.786648186544,"rank":8318,"this_scored_higher_than_pct":87,"this_scored_higher_than":58240,"rank_type":"exact","sample_size":66559,"percentile":87},"this_journal":{"total_number_of_other_articles":1152,"mean":7.0129348392702,"rank":354,"this_scored_higher_than_pct":69,"this_scored_higher_than":796,"rank_type":"exact","sample_size":1152,"percentile":69},"similar_age_this_journal_3m":{"total_number_of_other_articles":39,"mean":3.665,"rank":8,"this_scored_higher_than_pct":79,"this_scored_higher_than":31,"rank_type":"exact","sample_size":39,"percentile":79}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":2,"Student  > Ph. D. Student":1,"Student  > Master":2,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":2,"Chemistry":2,"Agricultural and Biological Sciences":2}}},"geo":{"mendeley":{"US":1,"CN":1}}},"posts":{"blogs":[{"title":"Takeda\u2019s Diabetes Drug Candidate TAK-875 In Phase III Trials","url":"http:\/\/cenblog.org\/the-haystack\/2011\/10\/takedas-diabetes-drug-candidate-tak-875-in-phase-iii-trials\/","citation_ids":[420155,420156,420157,420158,420159],"posted_on":"2011-10-19T16:13:00+00:00","summary":"Takeda Pharmaceutical today announced it has begun Phase III clinical trials of TAK-875, a first-in-class drug candidate for treating type 2 diabetes. The experimental therapy activates GPR40, a G-protein-coupled receptor that resides in pacreatic islet ce","author":{"name":"The Haystack","url":"http:\/\/cenblog.org\/the-haystack","description":"C&EN's pharmaceutical and biotech blog"}}]}}